 2017/02/23 07:06
主訴(Chief Complaint) 
Informant:family and medical records
Consciousness change with dyspnea since 2017/02/21 
病史(Brief History) 
This 64 years old female who is a nursing-home resident, has medical history of 
1.NSCLC, adenocarcinoma, EGFR exon 21 L858R mutation, cT2a(3)N0M1b stage IV, with brain metastasis, s/p craniotomy for tumor excision(brain tumor pathology: pleomorphic carcinoma, TTF1+, vimentin+), now on afatinib therapy (since 2016/02/18), with PR(2016/05/02, 2016/11/15 CT); with deteriorated neurologic status

According to the patient's statement, she had sudden onset left sided weakness and fell down on 2015/10/7. She could not recognized whether the weakness went first or falling down went first. She was sent to our ER, where CT scan showed two brain tumor with perifocal hemorrhage. Mannitol and solu-medrol was prescribed. MRI was performed and showed two tumor over right brain, suspected metastatic tumor. Whole body CT scan was performed and revealed bilateral lung tumor. She was then admitted to our ward on 2015/10/17 Right occipital craniotomy and Right fronto-parietal craniotomy for tumor excision was done on 2015/10/23. Right upper limb weakness was noted after the surgery, but her muscle power improved gradually. The pathology report of CT-guide Biopsy revealed adenocarcinoma, and the pathology report of the operation showed consistent with a metastatic pleomorphic carcinoma of pulmonary origin. She was discharged on 11/04 with oncology OPD follow up. WBRT and target therapy were suggested and she receive regular treatment in OPD. 
She was bedridden and could produce oriented speech as baseline performance. This time,  progressed consciousness change for 1 week was told by nursing home. On 2017/02/21 morning, dyspnea was noted. After contact with the patient's son, she was transferred to NTUH ER. On arrival to ER, vital sign showed T/P/R:37.6/154/32, SpO2=92%, BP=154/92, GCS:E2M1V1. Later BP decrease to 92/75 was noted and shock was impressed. Endotracheal tube intubation with fluid challenge, inotropic agents levophed were administered. CXR showed diffused increased infiltration. Lab data showed leukocytosis(WBC:15.72k, Band:27.6%, Seg:63.8%), ALT=335, protein uria(2+), pyuria, bacteriuria. Empirical antibiotics Tazocin was administered. Chest CT showed LUL lung cancer, stable. 
suspicious pulmonary infection, more prominent. Brain CT showed progression of tumor with some hemorrhage and leptomeningeal seeding. DNR was discussed with family and they agreed on DNR(除插管&ventilation). Hospice was consulted and combined care will be arranged. She was admitted to our ward for further care. 

Family History: husband died of lung cancer
Medication Allergy:No  舊病歷資料 2017/02/22
No  病人自述 2015/10/16
No  病人自述 2015/10/17
No  親屬描述 2015/10/23
No  病人自述 2015/10/24
Medication ADR:unknown
Allergy to Medical Device and Materials:No  舊病歷資料 2017/02/22
No  病人自述 2015/10/16
No  病人自述 2015/10/17
No  親屬描述 2015/10/23
No  病人自述 2015/10/24
Current Medication:
NTUH:警 Relaxin 500 mg/vial 不計價常備藥 50 mg STAT IV 1 days
TAZOCIN (based on piperacillin content) 2000 mg/vial 3000 mg Q6H IF 2 days
PCN Test (Penicillin G Skin Test) 1000 U/1 mL 2 mL/vial 0.1 mL ONCE ID 1 days
TAZOCIN (based on piperacillin content) 2000 mg/vial 3000 mg STAT IF 1 days
PARAMOL 500 mg/tab 1 tab STAT PO 1 days
PARAMOL 500 mg/tab 1 tab Q6HPRN PO 2 days
Zithromax 250 mg/tab 2 tab QD PO 3 days
Zithromax 250 mg/tab 2 tab STAT PO 1 days
Taita No.3 500 mL/btl 1500 mL QD IF 2 days
警 Levophed 4 mg/4 mL /amp 8 mg QD cIF 2 days
40 Giotrif 40 mg/tab 1 tab QODAC PO 14 days
MgO 250 mg/tab 1 tab TID PO 14 days
Other:
中草藥:nil
保健食品:nil
Past Medical History:
Hospitalization:入院日期:2015_10_17 出院日期:2015_11_04 診斷:Brain metastasis

Past Surgical History:2015_10_23  1. Right occipital craniotomy for tumor excision
2. Right fronto-parietal craniotomy for tumor excision
Travel History:nil 
社會心理相關評估(Psychosocial Assessment) 
Social Economic and Personal History
教育程度:大學
職業:退休
宗教信仰:基督教
婚姻狀態:喪偶
使用語言:國語 台語 
口述血型:A，RH:不清楚，輸血反應:
抽煙:沒有
喝酒:沒有
檳榔:沒有
物質濫用:沒有 
系統性回顧(Review of System) 
1.Systemic: weight loss(-), easy-fatigability-), night sweats(-)
2.Skin: petechiae(-), purpurae(-), skin rash(-), itching(-),
3.HEENT: headache(-),dizziness(-), blurred vision(-), strabismus(-), ocular pain(-), otalgia(-), otorrhea(-), hearing impairment-), tinnitus(-), vertigo(-), nasal stuffiness(-), nasal discharge(-), epistaxis(-), gum bleeding(-), sore throat(-),oral ulcer(-)
4.Cardiovascular: exertional chest tightness(-), nocturnal dyspnea(-), orthopnea(-) syncope(-), palpitation(-), intermittent claudication(-)
5.Respiratory: dyspnea(+), cough(+), chest pain(-), hemoptysis(-), productive cough (+), pleuritic chest pain(-)
6.Gastrointestinal: anorexia(-), nausea(-), vomiting(-), dysphagia(-), heartburn(-), acid regurgitation(-), abdominal fullness(-), hunger pain(-) midnight pain(-), constipation(-), diarrhea(-), melena(-), change of bowel habit(-), small caliber of stool(-), tenesmus(-), flatulence(-)
7.Urogenital: flank pain(-), hematuria(-), urinary frequency(-), urgency(-), dysuria (-), hesitancy(-), small stream of urine(-), impotence(-), nocturia(-), polyuria(-), oliguria (-)
8.Musculoskeletal: bone pain(-), arthralgia(-), myalgia(-), weakness(-) back pain(-)
9.Metabolic: heat intolerance(-), cold intolerance(-), thirsty(-)
10.Nervous: numbness (-), paresis/plegia (-), unsteady gait (-) 
身體檢查(Physical Examination) 
BH: 163 cm,  BW: 51 kg,
T: 36.4 °C,  P: 120 bpm,  R: 16 /min,
BP: 143 / 69 mmHg,
Pain score: 0 ,

General appearance: drowsy
HEENT: grossly normal 
   Eyes: conjunctiva: not pale,    sclera: not icteric
   Pupil Isocoric,   light reflex (R/L): +/+, prompt
   Neck: supple, JVE (-), LAP (-)
Chest: symmetric expansion, rhonchi(+), crackles(+), wheezing(+)
Heart: RHB, no obvious murmur audible
Abdomen: soft and flat, No tenderness
Bowel sounds: normal active, Liver / Spleen: Not palpable
Extremities: freely movable, pitting edema (-), cyanosis (-), petechiae (-), rash (-)
Peripheral pulses: symmetrically intact, moderate

神經學檢查(Neurological Examination)
Consciousness:
   GCS= E2  M1  Vt
Cranial nn.:
   I. olfaction =not performed 
   II.III. light reflex:+/+
   III, IV, VI (EOM)= not performed
   V. not performed
      corneal reflex =intact
   VII. facial movement =intact, no facial palsy
   VIII. hearing = no response to sound
   IX, X. uvular movement =not performed
          gag reflex =intact
   XI. head turning =not performed
       shoulder shrugging =not performed
   XII. tongue protusion =not performed
Motor:
   muscle power:
      right/left shoulder =5/5
      right/left elbow =5/5
      right/left wrist =5/5
      right/left hip =5/5
      right/left knee =5/5
      right/left ankle =5/5
   deep tendon reflex:
      right/left biceps =2+/2+
      right/left triceps =2+/2+
      right/left brachioradialis =2+/2+
      right/left knee jerk =2+/2+
      right/left ankle jerk =2+/2+
Sensory: not performed
Coordination:
   finger-nose-finger = not performed
   rapid alternating movement = not performed
Gait: not performed 
檢驗紀錄(Laboratory Report) 
*********檢驗室:RL***********

群組:CBC+PLT

               WBC           RBC           HB            HCT           MCV          
time/item      (K/μL)        (M/μL)        (g/dL)        (%)           (fL)         
1060221 [1459] 15.72         4.41          13.5          40.5          91.8         
1060222 [0435] 22.41         3.89          11.9          35.9          92.3         
               MCH           MCHC          PLT           RDW-CV        PS           
time/item      (pg)          (g/dL)        (K/μL)        (%)           ()           
1060221 [1459] 30.6          33.3          313           13.3          -            
1060222 [0435] 30.6          33.1          272           13.7          -            
群組:WBC Classification

               Blast         Promyl.       Myelo.        Meta          Band         
time/item      (%)           (%)           (%)           (%)           (%)          
1060221 [1459] 0.0           0.0           0.0           0.0           27.6         
1060222 [0435] 0.0           0.0           0.0           0.0           0.0          
               Seg           Eos.          Baso.         Mono.         Lym.         
time/item      (%)           (%)           (%)           (%)           (%)          
1060221 [1459] 63.8          0.0           0.0           2.9           5.7          
1060222 [0435] 95.4          0.0           0.1           2.3           2.2          
               Aty.Lym.      PlasmaCell    Normobl.      PS           
time/item      (%)           (%)           ()            ()           
1060221 [1459] 0.0           0.0           0.0           -            
1060222 [0435] 0.0           0.0           0             -            
群組:Coagulation

               PT            PTT           PT INR       
time/item      (sec)         (sec)         ()           
1060221 [1459] 10.0          24.4          0.93         
群組:General BioChemistry

               ALT          
time/item      (U/L)        
1060221 [1500] 335          
1060222 [0435] 282          
群組:Biochemistry

               CRE           Na            K             Ammonia N     T-BIL        
time/item      (mg/dL)       (mmol/L)      (mmol/L)      (μmol/L)      (mg/dL)      
1060221 [1459]                                           28                         
1060221 [1500] 0.2           130           4.3                         0.87         
1060222 [0435]                                                                      
               Lipase        LacticAcid   
time/item      (U/L)         (mmol/L)     
1060221 [1459]               2.87         
1060221 [1500] 44                         
1060222 [0435]               1.38         
群組:MULTISTIX

               Sp. Gr.(C)    pH(C)         Protein(C)    Glu.(C)       Ketones(C)   
time/item      (*)           (*)           (mg/dL)       (mg/dL)       (*)          
1060221 [1515] 1.021         6.5           100 ( 2+ )    300 ( 3+ )    -            
               O.B.(C)       Urobil.(C)    Bil.(C)       Nitrite(C)    WBC(C)       
time/item      (*)           (mg/dL)       (*)           (*)           (*)          
1060221 [1515] 1+            2.0           -             1+            2+           
               Color         Turbidity    
time/item      (*)           (*)          
1060221 [1515] Yellow        +            
群組:SEDIMENT

               RBC(S)        WBC(S)        EpithCell(S)  Cast(S)       Crystal(S)                 
time/item      (/HPF)        (/HPF)        (/HPF)        (/LPF)        (*)          
1060221 [1515] 2-5           50-75         0-2           Gr(0-2)       Amo-PO4(3+)  
               Bacteria      Others(S)    
time/item      (*)           (*)          
1060221 [1515] 4+            -            
群組:

               Troponin-T    eGFR          Mucus(S)     
time/item      (ng/L)        (mL/min/1.73  (*)          
                              m^2)                      
1060221 [1459] 22.52                                    
1060221 [1500]               377.7                      
1060221 [1515]                             -            
1060222 [0435] 21.95                                    
*********檢驗室:YM***********

群組:Yes

               pH            pCO2          pO2           HCO3          BaseExcess   
time/item      ()            (mmHg)        (mmHg)        (mmol/L)      (mmol/L)     
1060221 [1451] 7.519         34.5          76.0          28.4          5.3          
1060222 [0432] 7.500         34.2          88.2          26.9          3.5          
               SO2          
time/item      (%)          
1060221 [1451] 96.5         
1060222 [0432] 97.6         
群組:

               Free Ca(急重症自  Hb(急重症自行檢驗)   Hct(急重症自行檢驗)  K+(急重症自行檢驗)   Na(急重症自行檢驗)  
               行檢驗)                                                                               
time/item      (mmol/L)      (g/dL)        (%)           (mmol/L)      (mmol/L)     
1060221 [1451] 1.12          14.1          42            3.92          126.7        
1060222 [0432] 1.24          12.6          38            3.73          134.5        
               Suger(急重症自行檢  LacticAcid(急 
               驗)            重症自行檢驗)      
time/item      (mg/dL)       (mmol/L)     
1060221 [1451] 224           2.6          
1060222 [0432] 139           1.6          
*********檢驗室:PO***********

群組:

               Sugar(One to 
               uch)         
time/item      (*)          
1060221 [1456] 203          

*********檢驗室:B3***********
B3-1060221-1032138   SPUTUM (EXPECTORATED)
     Gram's(GS)#1:       Many PMNs ( >25 /LPF )
     Gram's(GS)#2:       Many epithelial cells ( >25 /LPF )
     Gram's(GS)#3:       Gram (+) rods,  Gram (-) rods 3+
     ID+DS Sputum Culture #1:       Mixed flora
     Gram's(GS)#4:       Gram (+) cocci in chains 3+
     Gram's(GS)#5:       痰檢體品質不良建議重新送檢

*********檢驗室:BK***********

群組:Blood Type

               ABO Typing    RH Typing    
time/item      (*)           (*)          
1060221 [1459] A             Positive     
群組:Yes

               antibody scr 
               een(New Lis)               
time/item      (*)          
1060221 [1459] Negative 
檢查紀錄(Examination Report) 
nil 
影像報告(Imaging Report) 
CT With/Without Contrast-Brain 醫令: CT With/Without Contrast-Brain 報告醫師: 李崇維 影像時間: 2017/02/21 16:37 (33072B0M) 發報告時間: 2017/02/21 17:15 CT scan of the brain without and with contrast enhancement shows:
1. Multiple heterogeneous enhancing lesions in pons, left midbrain, bilateral cerebellum, bilateral basal ganglia, bilateral cerebrum. They are enlarged and some show high-density change before contrast injection, suggesting tumor bleeding. The larger lesions are in right cerebellum, left perisylvian region, and right high posterior frontal lobe. Perifocal edema is noted. There is compression of brainstem. 
2. Mild hematoventricle.
3. Leptomeningeal enhancement in posterior fossa.
CT With/Without Contrast-Chest 醫令: CT With/Without Contrast-Chest 報告醫師: 黃昱森 影像時間: 2017/02/21 16:37 (33072B2M) 發報告時間: 2017/02/21 17:23 EXAMINATION: CT scan of chest, with/without iodine contrast enhancement. 
FINDINGS: 
(This study is read and compared with prior CT on 2016-11-15)
1. Lungs and pleura: A 1.9cm spiculated nodule at LUL abutting the mediastinal pleura, about 1.9cm stable. Pleural thickening and fibrotic change at right apical lung. peribronchial multiple tiny nodules and patchy consolidations at bilateral lungs, predominantly lower, with small left pleural effusion, suspicious infection.
2. Lymph nodes: no definite lymphadenopathy in the mediastinum or bilateral axillae. 
3. Mediastinum: atherosclerosis with wall calcifications at the aorta. 
4. Bone: thoracic spondylosis. 
5. Other soft tissue: small osteosclerotic lesion at L2 vertebra, non-aggressive. 
(please correlate with reports of other body parts).
Chest: AP View (Supine) 醫令: Chest: AP View (Supine) 報告醫師: 陳佾昌 影像時間: 2017/02/21 15:17 (32001CYM) 發報告時間: 2017/02/21 16:00 Chart No: 5681959
Accession No: T0172234695
EXAMINATION: Chest - AP View (Supine).
FINDINGS:
Bilateral lung consolidation. Placement of endotracheal tube, nasoenteric tube. Suggest clinical correlation.
Chest : PA View (Standing) 醫令: Chest : PA View (Standing) 報告醫師: 陳信銘 影像時間: 2016/12/13 09:54 (32001CXM) 發報告時間: 2017/02/08 13:30 Chest radiograph shows normal heart size and no definite active lung lesion.
Chest : PA View (Standing) 醫令: Chest : PA View (Standing) 報告醫師: 陳佾昌 影像時間: 2016/06/14 09:36 (32001CXM) 發報告時間: 2017/02/03 10:07 Chart No: 5681959
Accession No: T0160253520
EXAMINATION: Chest - PA View (Standing).
FINDINGS:
Normal heart size. Bilateral increased interstitial infiltration. This study is reassigned to current radiologist on 2017/02/03. 
病理報告(Pathology Report) 
S1542269
Lung,upper lobe, left,CT-guide biopsy,adenocarcinoma    
 S1543073
Brain,tumor,craniotomy and excision,pleomorphic carcinoma,metastatic    
Brain,peritumor,craniotomy and excision,pleomorphic carcinoma,metastatic 
臆斷(Tentative Diagnosis) 
1. NSCLC, adenocarcinoma, EGFR exon 21 L858R mutation, cT2a(3)N0M1b stage IV, with brain metastasis, s/p craniotomy for tumor excision(brain tumor pathology: pleomorphic carcinoma, TTF1+, vimentin+), now on afatinib therapy (since 2016/02/18), with PR(2016/05/02, 2016/11/15 CT); with deteriorated neurologic status
2. Pneumonia, with septic shock and respiratory failure, s/p ET+MV 
醫療需求與治療計畫(Medical Needs and Care Plan) 
*
1. NSCLC, adenocarcinoma, EGFR exon 21 L858R mutation, cT2a(3)N0M1b stage IV, with brain metastasis, s/p craniotomy for tumor excision(brain tumor pathology: pleomorphic carcinoma, TTF1+, vimentin+), now on afatinib therapy (since 2016/02/18), with PR(2016/05/02, 2016/11/15 CT); with deteriorated neurologic status
2. Pneumonia, with septic shock and respiratory failure, s/p ET+MV

P: 
1. NSCLC, multiple brain metastases, with consciousness change
2. Pneumonia, with septic shock and respiratory failure, s/p ET+MV
A:
Vital sign:T/P/R:36.4/120/16 BP:143/69
PE:breath sound:rhonchi(+), crackles(+), wheezing(+)
Lab:leukocytosis(WBC:15.72k, Band:27.6%, Seg:63.8%), ALT=335, protein uria(2+), pyuria, bacteriuria
Image:Brain CT showed progression of tumor with some hemorrhage and leptomeningeal seeding
P:
1. Monitor vital sign, GCS
2. Palliative care
3. Infection control with empirical Abx
Treatment Goal:
1. Palliative care 
2. BT<38oC. RR<20 
出院規劃(Discharge Planning) 
管路留置狀況:有
靜脈管路留置(含Hickman / Port-A)：有 左手 
雙腔導管留置：無  
鼻胃管留置：有 16Fr. 
氣管管路留置：有 氣管內管  7.0mm 
胃造廔口：無  
尿管留置：有  16Fr. 
膀胱造廔：無 
傷口引流管：無
其他導管：無
日常生活功能分數：0
預期出院後居住場所：與家人同住 
預期出院後主要照顧者：兒子 妹妹 
出院規劃收案篩檢：高危病患 帶有管路 功能量表未滿60分 
主治醫師評論(VS Comments) 
I agree with the assessment of the intern. 
醫師姓名 
郭律廷 主治醫師 
